Khadidja KESSAS

Mrs. Khadidja KESSAS

Biochemistry
+1
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2023 in Biochemical Pharmacology
Verified
Journal Article
Closed access
ZCZehor Chouari
Zehor Chouari
WLWafaa LOUNIS
Wafaa LOUNIS
IGImen GHZAIEL
Imen GHZAIEL
Khadidja KESSASKhadidja KESSAS
Khadidja KESSAS
Amira ZarroukAmira Zarrouk
Amira Zarrouk
OKOmar KHAROUBI
Omar KHAROUBI

24 February 2024 in Biochimie
Verified
Journal Article
Closed access
Khadidja KESSASKhadidja KESSAS
Khadidja KESSAS
WLWafaa Lounis
Wafaa Lounis
ZCZehor Chouari
Zehor Chouari
AVAnne Vejux
Anne Vejux
GLGérard Lizard
Gérard Lizard
OKOmar Kharoubi
Omar Kharoubi

13 January 2022 in Cells
Verified
Journal Article
Open access
PDF file
Khadidja KESSASKhadidja KESSAS
Khadidja KESSAS
ZCZehor Chouari
Zehor Chouari
IGImen GHZAIEL
Imen GHZAIEL
Amira ZarroukAmira Zarrouk
Amira Zarrouk
MKMohamed Ksila
Mohamed Ksila
OKOmar KHAROUBI
Omar KHAROUBI
Mitochondria are multifunctional organelles that participate in a wide range of metabolic processes, including energy production and biomolecule synthesis. The morphology and distribution of intracellular mitochondria change dynamically, reflecting a cell’s metabolic activity. Oxidative stress is defined as a mismatch between the body’s ability to neutralise and eliminate reactive oxygen and nitrogen species (ROS and RNS). A determination of mitochondria failure in increasing oxidative stress, as well as its implications in neurodegenerative illnesses and apoptosis, is a significant developmental process of focus in this review. The neuroprotective effects of bioactive compounds linked to neuronal regulation, as well as related neuronal development abnormalities, will be investigated. In conclusion, the study of secondary components and the use of mitochondrial features in the analysis of various neurodevelopmental diseases has enabled the development of a new class of mitochondrial-targeted pharmaceuticals capable of alleviating neurodegenerative disease states and enabling longevity and healthy ageing for the vast majority of people.